Monday, April 16, 2012

tera power leveling only fresh and dried - YBW

129788454829531250_47Purple Xin pharmaceutical shock: former Chairman Guo Chunsheng monitored live On April 12, the reporter was informed that Purple Xin Guo Chunsheng former Chairman and current Director of the drug industry by the relevant authorities had taken "residential surveillance" coercive measures. This information was first disclosed on session of the 31st meeting of the Standing Committee in Jilin province. Agenda show: March 23, by the 31st meeting of the second plenary meeting of Jilin provinceNPC Vice Chairman Zhou Huachen auspices, the first item on the agenda is "voting session of the Standing Committee on licensing the province's plenary session of the national people's Congress under residential surveillance enforcement Guo Chunsheng decisions". Jilin province according to people familiar with the matter said: "March 23 meeting of the national people's Congress tera gold, also announced the decision to oust Guo Chunsheng provincial people's Congress deputies. Since the introduction of the new criminal procedure law, JilinMonitored live in first person. "On April 12, purple Xin pharmaceutical secret Dong Zhong Yunxiang said:" in a couple of days ago, I visited Guo Chunsheng. He watched live, a Board of directors do not receive any information, cannot be released. "Guo Chunsheng cellphone is in a shutdown state. These people said: "why did not say on the national people's Congress."Strange to leave companies acknowledge the existence of" less time and the disclosure of related party transactions "problems, but has always denied the fictional performance. Purple Xin pharmaceutical industry has not yet notice Guo Chunsheng are monitoring live news. Adopted on March 14, laid down in the amendment to the criminal procedure law, residential surveillance applies to "comply with the conditions of arrest, but suffered from serious diseases cannot take care of sth Case ". This descriptionGuo Chunsheng problem has been "comply with the conditions of arrest". Guo Chunsheng is suffering from a serious heart disease, this may be the cause was under residential surveillance. Guo last appeared in public view, is on January 16, 2012 Board of Directors submitted his resignation from the company. Notices displayed at that time, Guo Readme "for a long time there has been a heavy heart disease, suddenly increased in recent days hospitalization, can take a long timeTreatment and rest, is not competent for the job, resigned as Chairman and General Manager of application functions ". Zhong Yunxiang said: "Guo Chunsheng is still the company's Director, resigned after his heart disease increased, by Cao Enhui Deputy Chairman. "Guo Chunsheng is trapped outside the company neiyou suddenly at the time of departure. Purple Xin pharmaceutical medical researcher in the eyes of the star unit is the road, because at the end of 2010Involved in the ginseng business performance surge, many institutions are recommended in early 2011 purple Xin pharmaceuticals. After a round of speculation, purple Xin pharmaceutical complex right after share prices reached the highest value of $ 65. But in about July 2011, information and continuing out purple Xin pharmaceutical industry "buy sell, results for the fictional" violations. Under the supervision of public opinions, acknowledge the existence of the company "Less time and the disclosure of related party transactions "problems, but has always denied the fictional performance. This event last year, pharmaceutical stocks the largest "Black Dragon". On October 19, 2011, Commission inspection Corps finds Zi Xin pharmaceutical alleged securities violations, official on their Office-inspection, inspection results to date has not been announced. Securities industry insiders said: "the Securities CommissionInvestigation of time after placing as the case may be, two or three year long. Purple Xin Pharmaceuticals has been placed for six months, is longer. "In the Commission during the investigation, Guo Chunsheng made his resignation on February 3, the purple Xin pharmaceutical industry's third largest shareholder on behalf of equity investment management companies are also in Changbai Mountains in Jilin Municipal SASAC small amounts of reduction of the 400,000 shares, its stake fall to 4.99%. "Shareholders, holding 5% the following, which continue to underweight will notice is no longer required. "The securities industry," said SASAC equity investment platform may be informed in advance of some information. "However, on February 23 Zi Xin pharmaceutical performance Express, company's 2011 annual revenues and profits continued to increase by more than 60%, the company attributed to the dramatic growth in the ginseng business�� "Listing" the first piece purple Xin pharmaceuticals successfully junior, became "listing" first works while Guo Chunsheng was under residential surveillance causes have yet to be announced but there are rumors that may be related to Executive Vice Governor of Jilin province has been investigated the original Tian Xueren related. 2007 purple Xin pharmaceutical industry prior to listing, Jilin province has 4 years there is no company in the domestic market. In 2005, the fieldJen led the establishment of the Office of listed enterprises in Jilin province, is intended to speed up the promotion of listed enterprises in Jilin province, expanding enterprises in Jilin Province the proportion of direct financing in the capital market. In 2006, the Jilin provincial government issued the notice about speeding up the cultivation and development of capital market guidance, explicit requirements for the province's IPO companies of not less than 5 per year. Inspired by the Government's strong, purpleXin pharmaceuticals successfully junior, became "listed" first puzzle. Day of the March 2, 2007, Tian Xueren also listed to Shenzhen to attend the ceremony. However, Zi Xin pharmaceutical industry dominated by traditional Chinese medicine at the beginning of the listed products, business has been poor. On November 11 tera power leveling, 2010, purple Xin pharmaceutical industry came all of a sudden intervention of ginseng industry, an explosion results-Growth. In only two months left in the year, purple Xin Pharmaceuticals "ginseng products" business income up to $ 359 million, far higher than other businesses. Zhong Yunxiang said: "the company in 2008 and have the ginseng business research, officially into 2010, 2010 simply fresh ginseng into pieces. Policy support on the local government, andNot willing to mention the existence of the concept, but clearly planning the 25 leading companies of ginseng industry bigger and stronger. "Purple Xin ginseng processing enterprises of pharmaceutical industry actually become tonghua's largest, only fresh and dried, you can get a lot of benefit, this is exactly what the main causes of road agencies bullish on its share price. Behind this cannot be achieved without policy preferences. In February 2008, Tian Xueren from the DeputyOn the Governor left office, transfer of Jilin Bank Limited was established in October 2007. Purple Xin pharmaceutical industry involved in the ginseng business after the end of 2010, rapidly launch saw a total private placement of up to 1 billion, raising money into the ginseng business, 6 industrial Global Fund participation of targeted placements. Raised $ 1 billion respectively into four special account, which plans to publicSecretary of Yanbian area $ 299.5 million deposited in a bank branch in Yanbian, Jilin province, as a special reserve. After that tera gold, the purple Xin pharmaceutical industry has also applied to the Bank of Jilin working capital loan of $ 300 million. Yanbian and ginseng in Jilin province, one of the main producing areas. November 5, 2011 Central discipline Inspection Commission disclosure Tian Xueren suspected of serious violations of, is receiving organization investigation. Has not publishedProgress. Related links feature: purple Xin Xin pharmaceutical industry accused of guangxia's second purple 53.69% purple Xin pharmaceuticals 2011 net profit of 266 million up pharmaceutical industry reduced performance in the first quarter of more than 80% Others:

No comments:

Post a Comment